Nadav Kidron Oramed Pharmaceuticals Inc. (ORMP) insider trading activity

ORMP Quotes by TradingView

Nadav Kidron is President and CEO of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 1.83 Million shares of ORMP, which is worth approximately $4.33 Million. The most recent transaction as insider was on Nov 07, 2024, when has been sold 45,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.83M
2.53% 3M change
25.76% 12M change
Total Value Held $4.33 Million

NADAV KIDRON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 07 2024
BUY
Grant, award, or other acquisition
-
45,000 Added 2.41%
1,826,098 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
329,000 Added 15.59%
1,781,098 Common Stock
May 26 2023
BUY
Grant, award, or other acquisition
-
120,000 Added 7.63%
1,452,098 Common Stock
Apr 17 2023
BUY
Grant, award, or other acquisition
-
279,000 Added 17.32%
1,332,098 Common Stock
Oct 27 2022
SELL
Bona fide gift
-
25,000 Reduced 2.32%
1,053,098 Common Stock
Aug 01 2022
SELL
Payment of exercise price or tax liability
$105,595 $8.36 p/Share
12,631 Reduced 1.16%
1,078,098 Common Stock
Jul 28 2022
BUY
Grant, award, or other acquisition
-
160,000 Added 12.79%
1,090,729 Common Stock
Jan 03 2022
SELL
Payment of exercise price or tax liability
$677,165 $13.89 p/Share
48,752 Reduced 5.21%
887,729 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
213,000 Added 18.3%
950,729 Common Stock
Dec 30 2021
SELL
Bona fide gift
-
20,000 Reduced 2.54%
766,481 Common Stock
Dec 28 2021
SELL
Payment of exercise price or tax liability
$411,829 $12.98 p/Share
31,728 Reduced 3.88%
786,481 Common Stock
Dec 03 2021
SELL
Bona fide gift
-
20,000 Reduced 2.39%
818,209 Common Stock
Aug 31 2021
BUY
Grant, award, or other acquisition
-
100,000 Added 11.78%
748,573 Common Stock
Aug 09 2021
SELL
Open market or private sale
$4,424,200 $20.11 p/Share
220,000 Reduced 25.33%
648,573 Common Stock
NK

Nadav Kidron

President and CEO
New York, NY

Track Institutional and Insider Activities on ORMP

Follow ORAMED PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ORMP